🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12123+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12123 recruiting trials

NARecruitingNCT06995014

Retrieval-based Word Learning in Developmental Language Disorder: Adaptive Retrieval Schedule

👨‍⚕️ Laurence B Leonard, PhD, Purdue University📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06526689

Lung Innate Immunity and Microbiome After Tuberculosis Exposure

👨‍⚕️ Helen McShane, PhD, University of Oxford📍 3 sites📅 Started Aug 2024View details ↗
Phase 4RecruitingNCT06294990

Klinefelter Syndrome and Testosterone Treatment in Puberty

👨‍⚕️ Lise Aksglaede, MD, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark📍 1 site📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06268665

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

👨‍⚕️ Eve Rodler, MD, University of California, Davis📍 1 site📅 Started Aug 2024View details ↗
Phase 1RecruitingNCT05687123

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

👨‍⚕️ Nikolaos Trikalinos, Yale University Cancer Center LAO📍 10 sites📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06467617

Adebrelimab Plus Chemo and Recaticimab in Perioperative Treatment of Resectable NSCLC

👨‍⚕️ Jinghui Wang, Director of Research Laboratory, Beijing Chest Hospital📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06547099

Study to Understand Novel Biomarkers in Researching Dementia

👨‍⚕️ Randall Bateman, MD, Washington University School of Medicine📍 1 site📅 Started Aug 2024View details ↗
Phase 1RecruitingNCT06308419

A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions

👨‍⚕️ Elise Nassif, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Aug 2024View details ↗
Phase 1RecruitingNCT06399640

Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

👨‍⚕️ Somedeb Ball, MD, Vanderbilt University/Ingram Cancer Center📍 1 site📅 Started Aug 2024View details ↗
Phase 1, PHASE2RecruitingNCT06592170

Linperlisib Combination With Obinutuzumab Frontline Treatment of Marginal Zone Lymphoma Patients (MZL)

🏥 The First Hospital of Jilin University📍 1 site📅 Started Aug 2024View details ↗
Phase 1, PHASE2RecruitingNCT04173650

MSC EVs in Dystrophic Epidermolysis Bullosa

👨‍⚕️ David T Woodley, MD, University of Southern California Dept of Dermatology📍 3 sites📅 Started Aug 2024View details ↗
NARecruitingNCT06529250

Intermediate-dose HAD Regimen for CEBPA Double-mutated AML

👨‍⚕️ Hui Wei, MD, Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College📍 1 site📅 Started Aug 2024View details ↗
Phase 3RecruitingNCT06545526

Chemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous Polyposis

🏥 Yonsei University📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06861530

A Swiss Assessment of Hypothalamic-pituitary-adrenal Axis Suppression After Glucocorticoid Therapy for Leukemia and Lymphoblastic Lymphoma in Children

🏥 University Children's Hospital Basel📍 2 sites📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06580574

Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers

👨‍⚕️ Lin Shen, Peking University Cancer Hospital & Institute📍 1 site📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06353906

Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer

👨‍⚕️ Michiel S. van der Heijden, PhD, The Netherlands Cancer Institute📍 2 sites📅 Started Aug 2024View details ↗
RecruitingNCT06396533

Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)

👨‍⚕️ Alexander Kutikov, M.D., Fox Chase Cancer Center📍 2 sites📅 Started Aug 2024View details ↗
NARecruitingNCT06783101

Using a Smart Inhaler to Support Asthma Management in Adolescents With Intellectual and Developmental Disabilities

👨‍⚕️ Larry Yin, MD, MSPH, Children's Hospital Los Angeles📍 1 site📅 Started Aug 2024View details ↗
Phase 3RecruitingNCT05847517

Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN)

👨‍⚕️ Borja Ibanez, MD PhD FESC, CNIC & Fundación Jiménez Díaz University Hospital📍 10 sites📅 Started Aug 2024View details ↗
Phase 3RecruitingNCT06435429

A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer

🏥 Jazz Pharmaceuticals📍 166 sites📅 Started Aug 2024View details ↗
← PreviousPage 256 of 607Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →